Biotinylated Anti-Human MIP-3β Antibody
- 产品详情
- 实验流程
Application ![]()
| WB, E |
---|---|
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Preparation | Produced from sera of rabbits pre-immunized with highly pure recombinant Human MIP-3β. Anti-Human MIP-3β specific antibody was purified by affinity chromatography and then biotinylated. |
---|---|
WesternBlot | To detect Human MIP-3β by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. When used in conjunction with compatible secondary reagents, the detection limit for recombinant Human MIP-3β is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions. |
Sandwich | To detect Human MIP-3β by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with BioGems' Polyclonal Anti-Human MIP-3β (60-228P) as a capture antibody, allows the detection of at least 0.2 – 0.4 ng/well of recombinant Human MIP-3β. |
Direct | To detect Human MIP-3β by direct ELISA (using 100 μl/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with compatible secondary reagents, allows the detection of at least 0.2 – 0.4 ng/well of recombinant Human MIP-3β. |
Formulation | A sterile filtered antibody solution was lyophilized from PBS, pH 7.2. |
Reconstitution | Centrifuge vial prior to opening. Reconstitute in sterile PBS containing 0.1% BSA to a concentration of 0.1-1.0 mg/ml. |
Storage | -20°C |
Precautions | Biotinylated Anti-Human MIP-3β Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
Research Areas
For Research Use Only. Not For Use In Diagnostic Procedures.
Application Protocols
Provided below are standard protocols that you may find useful for product applications.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.